Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Academisch Ziekenhuis Leiden has 3 pending office actions in Biotechnology & Pharmaceuticals. The matters are distributed across 3 distinct examiners and 3 distinct art units, giving each pending action a separate examination setting.
ZIMBOUSKI, ARIANA is the busiest examiner, with 1 pending matter. Counsel should use matter-specific preparation rather than assume a common examiner approach.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| §112 only | 1 (33%) |
| Double-patenting + other | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ZIMBOUSKI, ARIANA | 1 | 68.1% | +31.1% |
| DACE DENITO, ALEXANDRA GERALDINE | 1 | 54.5% | +32.6% |
| SHIN, DANA H | 1 | 26.9% | +26.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17119806 | METHOD FOR EFFICIENT EXON (44) SKIPPING IN DUCHENNE MUSCULAR DYSTROPHY AND ASSOCIATED MEANS | SHIN, DANA H | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17678311 | COMPOSITIONS AND METHODS FOR MODULATING ATAXIN 3 EXPRESSION | DACE DENITO, ALEXANDRA GERALDINE | 31d overdue |
| 18982672 | Arteriovenous Graft System | ZIMBOUSKI, ARIANA | — |
| 17119806 | METHOD FOR EFFICIENT EXON (44) SKIPPING IN DUCHENNE MUSCULAR DYSTROPHY AND ASSOCIATED MEANS | SHIN, DANA H | — |
| Art Unit | Apps |
|---|---|
| 3781 | 1 |
| 1636 | 1 |
| 1635 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18982672 | Arteriovenous Graft System | ZIMBOUSKI, ARIANA | 3781 | §112 | Non-Final OA | — | Pending | Dec 16, 2024 |
| 17678311 | COMPOSITIONS AND METHODS FOR MODULATING ATAXIN 3 EXPRESSION | DACE DENITO, ALEXANDRA GERALDINE | 1636 | §103 | Final Rejection | 31d overdue | Pending | Feb 23, 2022 |
| 17119806 | METHOD FOR EFFICIENT EXON (44) SKIPPING IN DUCHENNE MUSCULAR DYSTROPHY AND ASSOCIATED MEANS | SHIN, DANA H | 1635 | §112DP | Final Rejection | — | Pending | Dec 11, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAcademisch Ziekenhuis Leiden has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Ariana Zimbouski has the most, with 1 of Academisch Ziekenhuis Leiden's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
